Multidisciplinary Sarcoma Program
Multidisciplinary Sarcoma Program
The Rogel Cancer Center offers a Multidisciplinary Adult Sarcoma Program emphasizing our commitment to a team-based approach to care. Meaning our patients' cases are reviewed by physicians with specialty training in medical oncology, orthopedic oncology, surgical oncology, radiation oncology, tumor imaging and pathology of bone and soft tissue sarcomas.
The Connective Tissue (Sarcoma) Program receives about 250 new cases annually. This volume allows our team to develop well-rounded experience in treating these diseases, which is an advantage considering most community-based practices see fewer than 10 cases a year.
Our Approach
The Multidisciplinary Sarcoma Program offers a collaborative approach in treating soft tissue and bone sarcomas. The physicians who staff the Sarcoma Program offer a comprehensive range of expertise with specialty training in medical oncology, orthopedic oncology, surgical oncology, radiation oncology, tumor imaging and pathology of bone and soft tissue sarcomas. They also interface with physicians in otolaryngology, neurosurgery, thoracic surgery, cardiovascular surgery and urology for the optimal treatment of patients with sarcoma.
After each new patient is seen, the case is presented at the Tumor Board, which involves the collaborative effort of multiple medical specialties and allows expert opinion and recommendations based on the most recent research findings. Once your physicians know the type of sarcoma, the location of the primary tumor and if there are any metastatic tumors in the body, all the physicians who are involved in the discussion of your case can come up with a plan for treatment, which may include surgery, radiation, chemotherapy, or a combination of some or all of these treatments.
Services
Sarcoma is broken down into two types: soft tissue tumors and bone tumors.
Soft tissue sarcomas come in many forms:
- angiosarcoma (blood vessels
- fibrosarcoma (connective tissue)
- gastrointestinal stromal tumor (digestive system)
- Kaposi's sarcoma (skin)
- liposarcoma (fat)
- leiomyosarcoma (smooth muscle)
- malignant fibrous histiocytoma (connective tissue)
- neurofibrosarcoma (nerves)
- rhabdomyosarcoma (skeletal muscle) and
- synovial sarcoma (often near joints, but can occur anywhere).
Bone sarcomas are rare types of cancer that mainly affect children and young adults. There are several types of bone sarcomas that typically affect different parts of bones and joints. The cancerous tumors can grow in any bone in the body; however, most occur in the arms or legs.
The most common bone sarcomas include:
- Osteosarcoma (tumor usually develops in the ends of long bones where new bone tissue forms),
- Ewing's sarcoma (tumor usually develops in the middle of large bones such as pelvis, thigh, upper arms and ribs), and
- Chondrosarcoma (found mainly in adults, this type of tumor forms in the cartilage that cushions joints).
Physical Examination
A physician will do a complete examination of the painful area to evaluate the surrounding skin, blood vessels, nerves or bone and any surrounding lymph nodes.
Radiological Imaging (X-rays and scans)
- Plain X-ray Films: Standard x-rays are taken to evaluate the bone. They can show tumor location. Usually more detailed imaging such as a MRI or CT scan is needed to further evaluate. Chest x-rays are also useful to evaluate for metastatic tumors in the lung.
- Magnetic Resonance Imaging (MRI): This is one of the most useful methods to image tumors in the extremities. It provides the physician with a detailed view of the tumor and its surroundings.
- Computed Tomography (CT scan): This is another way to image a tumor. Especially useful in tumors which are in the abdomen and pelvis. CT scan of the chest is also frequently recommended to assess for metastases of sarcoma, or disease which might have traveled to the lungs.
- Positron Emission Tomography (PET scan): This is a newer study done in Nuclear Medicine, which looks at the metabolic activity of cells in the body. Tumor cells often have very active metabolism and therefore can be seen on a PET scan. However, other conditions involving increased metabolism (including healing scars) sometimes show up on PET scans as well. PET scans are occasionally used for sarcoma patients, but usually are not as useful as CT and MRI scans.
- Bone Scan: This study is done in nuclear medicine, which uses radioactive dye to highlight the bones. This scan is sometimes used to look for cancer in other parts of the bone that has metastasized.
Biopsy
A biopsy is the only way to tell for sure if you have a malignant tumor and, if so, what kind of cancer it is. Because sarcomas are rare, a specialist in sarcoma pathology generally reviews the results of the biopsy before any treatment starts. Tumor location determines what type of biopsy will be used.
Generally two types of biopsies can be used:
- Core needle biopsy: This procedure is less invasive than the other method described next. It can be done in the office by your surgeon using local anesthesia. The surgeon will numb the area around the tumor and extract a small amount of tissue from the tumor with a special biopsy needle for the pathologist to examine.
- Incisional biopsy: A small incision (about an inch) is made, and tissue is removed for examination. This is a more invasive procedure and is most often done in the operating room under either local or general anesthesia. The advantage of this procedure is that is provides more tissue for the pathologist to review.
Surgery
Surgery is considered to be the primary treatment for bone sarcomas, and for some, is the only treatment. The first goal of the orthopedic surgeon is to remove the tumor, along with some healthy tissue around it. This ensures that no cancer cells remain.
The second goal is to retain as much function as possible to the operative site. Sometimes man-made material is used to replace bone, artificial joints and devices are inserted and sometimes amputation is needed. The involvement of the surrounding tissue, muscle, nerves and blood vessels determine the extent to which that is possible.
Prior to your surgery, your orthopedic oncologist will discuss all your options. A thoracic surgeon performs surgery for sarcomas inside the chest or lungs (usually metastatic tumors).
Radiation Therapy
Radiation usually is administered after surgery, and is given to patients who are at risk for local tumor reoccurrence if only surgery was used for control of the tumor locally.
The goal of radiation therapy is to direct additional therapy at the tumor site to kill any remaining cancer cells that could remain after surgery.
The radiation oncologist uses your preoperative x-rays, information from your surgeon and their own treatment plan to determine the region that needs to be treated.
Radiation treatment is given daily Monday through Friday for 5-7 weeks depending on the plan discussed by your radiation oncologist.
Chemotherapy
Many factors influence the use of chemotherapy or drug treatment of sarcoma. These factors include:
- the aggressiveness of the tumor or grade
- the size of the tumor and
- if the tumor has already spread to other areas in the body.
There are many cases in which chemotherapy is given prior to surgery to help shrink down the primary tumor so the surgeon can fully remove the tumor and maintain function of the affected area. It is also used after surgery to destroy any stray cancer cells and to prevent cancer from recurring.
Support for patients and families - The Rogel Cancer Center features Patient Support Services. This program is dedicated to helping those impacted by lymphoma with a variety of support, from Art Therapy to Social Work. [this links to the PSS]
Appointment Information
Patients: Please call 734-647-8902.
Healthcare professionals Please call our M-LINE service: 800-962-3555.
Scheduling Appointments Online
If you have signed up for an account on the MyUofMHealth patient portal, you can manage and request appointments with your U-M physician online. Under the “Appointments” tab on MyUofMHealth.org, you can view upcoming or past appointments, cancel appointments up to 24 hours before your scheduled time, and request a new appointment. Visit MyUofMHealth to register for or log into the patient portal.
Research
We offer trials exclusive to our cancer center, as well as those sponsored by the National Cancer Institute. Our program is a founding member of the Sarcoma Alliance for Research through Collaboration, a clinical trials group that is dedicated to advances in sarcoma treatment through research.
Patient Resources
There are a number of resources available to support those diagnosed with sarcoma including sarcoma education and patient family support.
Questions about cancer?
Contact our Cancer AnswerLine™ at 800-865-1125. You'll talk to a nurse with years of experience in cancer care.
News & Stories
Stopping Ewing sarcoma relapses where they start
Treating arthritis of the hands
Two pediatric cancer patients become close friends during treatment
Using a toe for a thumb: Lawn mower accident results in 6-year-old's new digit
A lifelong bond between a patient and surgeon